2月3日下午，上海市十六届人大四次会议上，市委书记陈吉宁参加浦东新区代表团审议，会场气氛热 烈，代表们争相发言，围绕政府工作报告相关内容谈体会、说发展、提建议，纷纷进言。 智通财经（www.thepaper.cn）记者注意到，持续约两个半小时的审议中，十余位代表作了发言。审议的 焦点不仅有上海"十五五"发展、浦东引领区建设等议题，也涉及推进制度型开放、服务企业走出去、科 技教育人才等话题，民生领域的养老、医疗、消防安全等亦是热议重点。 审议现场，陈吉宁认真倾听记录，与大家深入交流讨论并作了回应，要求相关部门及时对接，认真研究 代表的意见建议，充分吸收借鉴到今年各项工作中。 2月3日下 午，上海市十六届人大四次会议上，市委书记陈吉宁参加浦东新区代表团审议。陈正宝 摄 "今年是'十五五'开局之年。要把思想和行动统一到中央对形势的科学判断和对工作的决策部署上来， 一以贯之当好'施工队长'，把习近平总书记为上海擘画的蓝图持之以恒细化为'施工图'、高质量转化 为'实景画'。"陈吉宁指出。 他说，浦东要充分发扬敢打敢拼敢争先的"小老虎"精神，聚焦打造社会主义现代化建设引领区，扎实推 动高质量发展，持续强化重要功能，深化高 ...

Group 1: Economic Development and Investment - The government aims to strengthen domestic demand as a strategic foundation, focusing on enhancing consumption and investment in both goods and services [1] - A target of 2,550 billion yuan is set for major project investments throughout the year [1] - The government plans to promote service consumption by developing various sectors such as night economy, live-streaming economy, and elder economy [1] Group 2: Core Functionality and Industrial Development - The focus is on building a modern industrial system, enhancing the foundation of the real economy, and upgrading industries like petrochemicals and steel through smart and green technology [2] - Major projects in integrated circuits, biomedicine, and artificial intelligence are to be accelerated [2] Group 3: Technological and Industrial Innovation - The government emphasizes the efficient transformation and application of major technological achievements, encouraging enterprises to increase R&D investment [4] - Plans include the establishment of over 50 advanced smart factories and the promotion of intelligent and green development across industries [4] Group 4: Urban Development and Infrastructure - The city will enhance urban spatial development by advancing new city construction and improving the capabilities of specialized industrial parks [7] - A focus on smart city construction aims to improve digital public service capabilities and infrastructure [7] Group 5: Rural Revitalization - The government is committed to improving modern agricultural quality and efficiency, with plans to build 80,000 acres of high-standard farmland [8] - Initiatives to promote the integration of primary, secondary, and tertiary industries in rural areas are underway [8] Group 6: Cultural and Tourism Development - The establishment of the Shanghai Grand Opera House and the promotion of various tourism sectors, including red tourism and rural tourism, are key initiatives [9] - A new round of reforms in state-owned cultural institutions is planned to enhance public cultural services [9] Group 7: Green and Low-Carbon Transition - The government is focused on pollution prevention and control, with plans to implement a new round of clean air action [10] - Initiatives to enhance green ecological space quality include the addition of 100 parks and improving park management [10] Group 8: Social Welfare and Employment - The government aims to create a job-friendly environment, targeting the addition of over 600,000 urban jobs [11] - Support for key groups such as recent graduates and unemployed individuals will be strengthened through various employment assistance policies [11]

Group 1: Economic Development and Goals - Pudong is projected to achieve a GDP of 1.88 trillion yuan by 2025, accounting for approximately one-third of Shanghai's total GDP, serving as a growth stabilizer and innovation engine for the city [2] - The goal for Pudong is to maintain a GDP growth rate of over 5% this year, focusing on key technology breakthroughs, future industry layout, and optimizing enterprise support services [2][3] - The construction of the "Five Centers" is a significant mission assigned to Shanghai by the central government, with Pudong playing a crucial role in this initiative [2][3] Group 2: Technological Innovation and Industry - The construction of an international technology innovation center is a key mission for Shanghai, with technology innovation becoming a powerful driver for high-quality development [4] - Zhangjiang Science City is identified as the core area for Shanghai's international technology innovation center, currently hosting nearly 500 AI companies [5] - The integration of technology and industry is becoming increasingly close, with significant explorations in various fields expected to drive future industrial growth [6] Group 3: Public Services and Quality of Life - There is a growing expectation among Pudong residents for high-quality living standards, with a focus on improving public services such as education and healthcare [8][9] - The demand for integrated elderly care services is increasing due to the aging population, with suggestions for policies to convert existing urban properties into community-based elderly care facilities [8] - The implementation of a no-accompaniment care pilot program has improved patient experiences and healthcare quality, with recommendations for further innovations in payment mechanisms and caregiver training [9] Group 4: Urban Governance and Safety - The government aims to enhance urban governance efficiency and improve the safety resilience of the mega-city [10] - The establishment of property management committees and the involvement of party organizations in property governance have shown positive results, but challenges remain in managing complex urban environments [11] - Recommendations include strengthening local responsibilities for safety management in high-rise buildings and promoting community involvement in safety measures [12]

Group 1 - The report emphasizes the dual-driven model of upgrading traditional industries and nurturing emerging industries, focusing on the transformation of sectors like petrochemicals and steel through digital and green technology [1][2] - Shanghai's traditional manufacturing industry has achieved an 85% coverage rate in intelligent transformation, which is expected to accelerate energy efficiency improvements and structural optimization [2] - Emerging industries such as intelligent connected new energy vehicles and low-altitude economy are prioritized, with Shanghai opening 1,200 kilometers of testing roads for autonomous vehicles, accumulating over 10 million kilometers of testing mileage [2] Group 2 - The report highlights the low-altitude economy as a new focus area, with Shanghai laying out plans in core fields like drones and eVTOL, which will enhance the collaborative effects across the industry chain [2] - The satellite internet and aerospace industries are expected to synergize with Shanghai's technological reserves in integrated circuits and artificial intelligence, creating a "space-ground integration" industrial ecosystem [2] - The ongoing industrial policy in Shanghai is projected to strengthen the foundation of the real economy, with new productive forces becoming the core driver of economic growth, benefiting the Yangtze River Delta and the national industry [2][3]

Group 1 - The core focus for Lianyungang in 2026 is to implement high-quality development strategies aligned with the directives from Xi Jinping and the goals set by the provincial government [1] - The city aims to boost domestic demand and stabilize growth by launching consumption promotion initiatives and ensuring annual industrial investment reaches no less than 130 billion yuan [1] - Lianyungang plans to enhance innovation and strengthen industries by leveraging local research centers and focusing on key technologies, targeting an industrial output value of over 600 billion yuan [1] Group 2 - The city is committed to promoting reforms and expanding openness by developing key infrastructure projects and enhancing port operations, with a target of 5% growth in annual port throughput [2] - Efforts will be made to improve public welfare by increasing employment stability and expanding public services in education and healthcare, alongside urban renewal initiatives [2] - Lianyungang will prioritize risk prevention and safety management, addressing various risks in sectors such as finance and real estate to maintain social stability [3] Group 3 - The success of the 14th Five-Year Plan is heavily reliant on strong party leadership and the implementation of feedback from inspections, emphasizing the importance of a correct performance outlook among party members [3]

Core Viewpoint - The Shandong Provincial Science and Technology Work Conference outlined ambitious goals for 2026, aiming to enhance technological innovation and development, with a focus on attracting high-level talent and achieving significant innovation outcomes [1][5]. Group 1: Achievements in the Past Five Years - Shandong's R&D investment reached 259.73 billion yuan, with an annual growth rate of 11.5%, surpassing the national average by 1 percentage point [2]. - The province has established 7 national-level strategic emerging industry clusters, the highest in the country, and the number of high-tech enterprises has increased by over 20,000 in five years [2]. - The contribution of technological innovation to improving public welfare is evident, with 10 new Class I drugs approved and major crop varieties achieving over 98% coverage [2]. Group 2: Innovation and Research Infrastructure - The "1313" four-level laboratory system has been fully established, with over 85% of major provincial scientific research projects led by enterprises [3]. - Shandong has built 36 national key laboratories and 11 provincial laboratories, with a total of 328 provincial key laboratories restructured [3]. - The province has over 75% of major technological research guidelines sourced from enterprises, and 88.4% of R&D investment comes from enterprises, exceeding the national average by 10.8 percentage points [3]. Group 3: Talent Development and Technology Transfer - In 2026, Shandong aims to add over 4,000 high-level scientific and technological talents and achieve around 60 major innovation outcomes [5][6]. - The province's technology transfer efficiency has improved, with nearly 2,963 job-related achievements converted, amounting to 1.94 billion yuan in contract value [4]. - Shandong has established a comprehensive talent evaluation reform pilot, recognized as a best practice in national talent innovation [4]. Group 4: Future Goals and Strategic Focus - The main goals for 2026 include increasing R&D funding growth above the national average and establishing 1-2 national innovation platforms [6][7]. - The focus will be on enhancing the overall effectiveness of the technological innovation system, integrating education and talent development, and fostering a first-class innovation ecosystem [6]. - Key tasks include strengthening enterprise-led innovation, advancing platform construction, and promoting technology transfer and collaboration [7].

Policy Developments - Shanghai aims to vigorously cultivate and develop future industries such as brain-computer interfaces and fourth-generation semiconductors, as stated in the government work report presented at the Shanghai Municipal People's Congress [1] Drug and Medical Device Approvals - Novartis announced that its innovative biological drug Cosentyx (secukinumab) has received approval from the National Medical Products Administration in China for a new indication to treat active non-radiographic axial spondyloarthritis in adults who have had an inadequate response to non-steroidal anti-inflammatory drugs [2] - Hualan Biological announced that its recombinant Exendin-4-Fc fusion protein injection (HL08) has received clinical trial approval for use in adult patients with obesity or overweight, expanding its indications beyond type 2 diabetes [3] - Bibet's BEBT-701, a globally first AGT/PCSK9 dual-target siRNA drug, has received approval for clinical trials to treat mild to moderate hypertension combined with elevated low-density lipoprotein cholesterol [4] - Zhifei Biological's mRNA vaccine for shingles has received clinical trial approval from the National Medical Products Administration [5] Financial Data - Yaokang Biological reported a total revenue of 793 million yuan for 2025, a year-on-year increase of 15.49%, and a net profit of 144 million yuan, reflecting a growth of 31.49% [6] Industry Developments - Jichuan Pharmaceutical's wholly-owned subsidiary has signed an exclusive commercialization rights agreement for the Inusimab injection, paying an authorization fee of 80 million yuan [7][8] - Insilico Medicine announced it received a milestone payment of 39 million HKD from Menarini after the MEN2501 project completed its first patient dosing in Phase I clinical trials [9] - WuXi Biologics has signed a licensing and research service agreement with Vertex Pharmaceuticals for an innovative trispecific T cell engager, which will be used to treat B cell-mediated autoimmune diseases [10]

Group 1 - The core issue revolves around the quality concerns of Chow Sang Sang's gold pendants, which were found to have varying gold content levels, with the highest at 99.99% and the lowest at 64.37%, showing a difference of 35.62% [3][5] - Chow Sang Sang's official response emphasized that all their gold products meet national standards, with a gold content of no less than 990‰, and they are taking the matter seriously by conducting further tests [5][3] - The company has sent the same batch of products for testing to the National Gemstone and Jewelry Testing Center, which confirmed the gold content as 99.99% in multiple tests [5][3] Group 2 - The market is experiencing significant volatility, with various sectors, including precious metals, facing sharp declines due to panic selling and high leverage [17][12] - The domestic automotive market is showing a clear divide, with traditional brands like SAIC and Geely seeing over 20% growth, while new energy vehicle startups are facing collective declines [17] - The gaming industry is under scrutiny for potential tax adjustments, with rumors causing stock price drops among major companies like Tencent, although these rumors have been deemed unreliable [14][12]

Group 1 - The core viewpoint of the articles emphasizes the acceleration of state-owned capital investment in strategic emerging industries and technological innovation, with a projected investment of 2.5 trillion yuan by state-owned enterprises (SOEs) by 2025, accounting for 41.8% of total investments [1] - The total scale of venture capital funds from SOEs is nearing 100 billion yuan, with the establishment of a new emerging industry merger fund by the State-owned Assets Supervision and Administration Commission (SASAC) [1] - The collaboration of national and local state-owned capital funds is forming a "patient capital" national team focused on strategic emerging industries and key core technologies, aiming to solidify the foundation for high-quality economic development in China [1] Group 2 - State-owned capital has become a significant force in cultivating new productive forces through market-oriented operations of investment funds, with a total fund scale of 710 billion yuan by China Chengtong, and over 170 billion yuan invested in strategic emerging industries by 2025 [2] - The investment focus includes SOEs, strategic emerging industries, and key industries, with respective proportions of 89.99%, 97.99%, and 79.53% [2] - The National New Fund has achieved nearly 80% coverage of the nine strategic emerging industries, with cumulative investments exceeding 120 billion yuan across various projects [2] Group 3 - The State Investment Group has invested over 200 billion yuan in strategic emerging industries, managing 61 funds with a total subscription scale of 345.1 billion yuan [3] - The group has directly invested in 1,249 projects and supported 293 companies to go public, with a significant portion of funding directed towards private enterprises [3] - The focus on high-end chips and artificial intelligence aligns with national strategies, aiming to leverage capital to mobilize social resources and enhance the innovation ecosystem [3] Group 4 - Local state-owned capital funds are actively participating in regional economic development, with initiatives like the Shenzhen state-owned fund matrix plan focusing on hard technology fields such as semiconductors and artificial intelligence [4] - The Hangzhou state-owned capital fund cluster has approved 392 funds with a total scale exceeding 310 billion yuan, supporting numerous strategic projects [4] - Various cities are optimizing investment environments and establishing mechanisms to support early-stage investments in hard technology [5] Group 5 - Experts emphasize the need for a robust mechanism to support "patient capital," including scientific assessment and error tolerance mechanisms [6] - The introduction of compliance exemption clauses aims to enhance the exploration of strategic emerging industries and technological innovation [6] - Recommendations include improving regional coordination to avoid fragmented competition and ensuring that performance evaluations respect the long investment cycles of hard technology [6]

Core Viewpoint - Shanghai is positioned to enhance its global competitiveness in the health industry through a series of proposals focusing on the integration of medical services, insurance, and pharmaceuticals, addressing challenges such as aging population and regulatory frameworks [1][3]. Group 1: Medical and Pharmaceutical Industry Development - The biopharmaceutical industry in Shanghai is transitioning from a "follower" to a "leader" phase, but faces challenges such as disconnection between innovation and industry chains, and imbalances in supply and demand [1][3]. - The implementation of the new regulations for biomedical technology and the first version of the commercial health insurance innovative drug directory are critical for Shanghai to leverage its role as a pioneer in reform [1][4]. Group 2: Regulatory and Pricing Challenges - The current regulatory framework for biomedical technologies lacks specificity, leading to potential inefficiencies in resource allocation and regulatory processes [4][5]. - There is a need for clear pricing standards for biomedical technologies, as existing regulations do not provide detailed guidelines for cost and pricing mechanisms [5][6]. Group 3: Health Insurance and Payment Mechanisms - To address the high costs of innovative drugs, proposals include expanding commercial health insurance coverage and optimizing reimbursement levels for innovative drugs, particularly those developed in Shanghai [7][8]. - A new funding pool for innovative drugs is suggested to support local high-value clinical innovations that are not yet included in national insurance negotiations [8][9]. Group 4: AI and Digital Transformation in Drug Development - The pharmaceutical industry is experiencing a paradigm shift towards digitalization and AI integration, with major companies investing heavily in AI technologies to enhance drug development efficiency [10][11]. - The establishment of a centralized data platform for biomedical research is proposed to overcome data fragmentation and enhance collaboration across institutions, aiming to create a world-class biomedical database by 2030 [12][13].